4.5 Article

Perfusion CT Findings in Patients With Metastatic Carcinoid Tumors Undergoing Bevacizumab and Interferon Therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Radiology, Nuclear Medicine & Medical Imaging

Perfusion CT in Patients With Metastatic Renal Cell Carcinoma Treated With Interferon

Chaan S. Ng et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

Body Perfusion CT: Technique, Clinical Applications, and Advances

Avinash R. Kambadakone et al.

RADIOLOGIC CLINICS OF NORTH AMERICA (2009)

Article Medicine, General & Internal

Sorafenib in advanced hepatocellular carcinoma

Josep M. Llovet et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Oncology

Imaging of neurcendocrine tumors

Eric P. Tamm et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)

Article Radiology, Nuclear Medicine & Medical Imaging

Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: Initial observations

DV Sahani et al.

RADIOLOGY (2005)

Article Oncology

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis

Z von Marschall et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)

Review Oncology

Carcinoid - A comprehensive review

II Schnirer et al.

ACTA ONCOLOGICA (2003)

Article Oncology

Functional computed tomography in oncology

KA Miles

EUROPEAN JOURNAL OF CANCER (2002)

Review Biotechnology & Applied Microbiology

Functional CT: physiological models

Ting-Yim Lee

TRENDS IN BIOTECHNOLOGY (2002)

Article Oncology

Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy

Y Seppenwoolde et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)

Article Oncology

New guidelines to evaluate the response to treatment in solid tumors

F Duffaud et al.

BULLETIN DU CANCER (2000)

Article Oncology

New guidelines to evaluate the response to treatment in solid Tumors

P Therasse et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)